Israel Active

The Nitric Oxide Nasal Spray, developed by Israeli-founded, Canada-based SaNOtize (reported previously) has proved 99.9% effective in lab tests by Utah State University’s Antiviral Research Institute. Phase 2 trials continue in Canada and are just beginning in UK hospitals.

Some 100 Israelis with severe allergies are being vaccinated at Israel’s Sheba Medical Center as part of a pilot program.  Previously, those with severe allergies were turned away from health clinics because of the risk of serious reactions, including anaphylactic shock.

2 million+ Israelis have had their first Pfizer vaccination. Prime Minister Benjamin Netanyahu was the first of over 110,000 Israelis to receive the second dose. He also announced that Israel could be the first nation to be fully vaccinated. Inoculation of teachers and the over-50s has begun; the over-40s will start shortly.

Israel’s Ceretrieve has designed and developed CathTrap, a unique catheter for neuro-thrombectomy - the fast and safe removal of blood clots from the brain that are the common cause of strokes. The CathTrap device has an expandable soft tip that enlarges its diameter to encompass the whole clot.

The first 120,000 doses of the 6 million coronavirus vaccines ordered from Moderna have arrived in Israel. These are to be primarily used to vaccinate homebound citizens. Over 1.5 million Israelis have now received their first vaccination and millions more Pfizer vaccines are arriving this coming week.

There are three HBOT (Hyperbaric Oxygen Therapy) centers in Israel. Citizens can get treatment for 15 conditions including decompression sickness, wound healing, and strokes. But it can potentially also treat PTSD, cerebral palsy, complex pain, fibromyalgia, cognitive decline and even aging.

Israel’s Matricelf has won Calcalist’s StartUp+ competition for its platform that enables 3D printing of tissues and organs. Matricelf developed the technology that Tel Aviv University scientists used to 3D print the first heart produced from human tissue (as reported previously).

The breakthrough SpinCare wound protection system from Israel’s Nanomedic (reported previously) is now being used in hospitals in the UK, Germany and Switzerland. The news was reported in the normally anti-Israel UK Guardian.

Israel’s IMedis (reported previously) has received European CE approval for its AI-based quality control system for radiology departments. The IMedis system can identify anomalies that may be missed by the radiologist in an initial reading, that may otherwise lead to cancer.

Surgeons at Israel’s Galilee Medical Center successfully replaced the knee joints of two Israeli women. They used robots to adapt the implants to the precise anatomical structure of the patients. In addition, the surgeons were able to simulate the surgery in advance and in real time.